We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. New data from the EVAS FORWARD Global Registry ...
The lack of any presence of endoleak at the initial imaging after endovascular aortic aneurysm repair (EVAR) is predictive of good midterm outcomes with less need for reintervention. As such, patients ...
The US Food and Drug Administration (FDA) is warning physicians that data from both clinical and industry sources suggests that the occurrence of Type III endoleaks in patients who have undergone ...
A literature search was carried out for this briefing in accordance with the interim process and methods statement. This briefing includes the most relevant or best available published evidence ...
Type IV endoleak is a very rare complication observed after implantation of aortobiiliac stent grafts. The difficult diagnosis of type IV endoleak leads to the application of many imaging methods in ...
Please provide your email address to receive an email when new articles are posted on . The FDA is evaluating the increased occurrences of type IIIa and type IIIb endoleaks associated with ...
Thirty-four patients (63%) survived for 30 days (perioperative mortality rate of 37%) (figure 1). The median follow-up for these 34 patients was 32 months (14–48 months). Twenty-five patients survived ...
PIUR tUS (3D tomographic ultrasound; PIUR imaging) generates 3D tomographic ultrasound images of the entire length of a blood vessel by extending regular 2D ultrasound scanners. This imaging can be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results